Tuesday 3 June 2025
  • About
  • Contact
  • Login
  • VC & Investment
  • M&A
  • AI
  • Podcasts
  • News
    • Pharmaceutical News
    • Biotechnology News
    • Generics News
    • Biosimilars news
    • In Brief
    • Legal
    • Company Pages
    • In The Boardroom
  • Insights
    • Analysis
    • Special Report
    • Interviews
    • Expert View
    • From Our Correspondent
    • One To Watch Companies
    • Digital Pharma
    • Pharma Leaders
  • Regulatory
    • FDA
    • EMA
    • Pricing, Reimbursement and Access
    • Regulation
    • Government Affairs
    • Trump Administration
  • Therapy Areas
    • Dermatologicals
    • Oncology
    • Neurological
    • Rare Diseases
    • Hematology
    • Cardio Vascular
    • Diabetes
    • Cell And Gene Therapy
  • Conferences
    • JPM Healthcare Conference
    • ESMO
    • ASCO
    • ASH
    • EULAR
    • AAIC
    • EASD
    • Forthcoming Events
  • Ones to Watch
  • About
  • Contact
  • Newsletter
  • Sign inSubscribe
Subscribe
  • Home
  • Cell and Gene Therapy

Cell and Gene Therapy

Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news

Today's issue

Elinzanetant cuts hot flushes associated with endocrine therapy for breast cancer
Pharmaceutical
Elinzanetant cuts hot flushes associated with endocrine therapy for breast cancer
2 June 2025
Pharmaceutical
Camizestrant results ‘pivotal moment in breast cancer care’
2 June 2025
Biotechnology
Opdivo SC wins EC approval
2 June 2025
Biotechnology
ASCO Tecentriq data a ‘landmark’ in dMMR colon cancer
2 June 2025
Pharmaceutical
Hansoh licensing deal provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist
2 June 2025
Biotechnology
BMS acquires rights to BioNTech’s bispecific antibody candidate BNT327
2 June 2025
Biotechnology
VectorY Therapeutics appoints Jessica Atkinson as CBO
2 June 2025

Company Spotlight

A Munich, Germany-based biotech company in the antibody drug conjugate (ADC) space.




The Pharma Letter

39-43 Putney High Street, Putney
London, SW15 1SP
United Kingdom

  • About us
  • Contact
  • Subscribe
  • Sponsorship/advertising


  • Terms and Conditions
  • Privacy Policy
  • Twitter
  • Linkedin

Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze